← All companies

EVAX

Evaxion A/S

EVAX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$2.79

-0.04 -1.41%

Key statistics

from XBRL data in SEC filings

Market cap

$1.16B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$2.52 – $12.15

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 17, 2026 6-K FORM 6-K Jul 13, 2026 6-K FORM 6-K Jul 1, 2026 6-K FORM 6-K Jun 12, 2026 6-K FORM 6-K Jun 11, 2026 6-K FORM 6-K May 12, 2026 6-K FORM 6-K May 7, 2026 6-K FORM 6-K May 4, 2026 6-K FORM 6-K Apr 27, 2026 6-K FORM 6-K Apr 22, 2026 6-K FORM 6-K Apr 17, 2026 6-K FORM 6-K Apr 17, 2026 6-K FORM 6-K Apr 16, 2026 6-K FORM 6-K Apr 7, 2026 6-K FORM 6-K Mar 30, 2026 6-K FORM 6-K Mar 19, 2026 6-K FORM 6-K Mar 19, 2026 6-K FORM 6-K Mar 17, 2026 6-K FORM 6-K Mar 5, 2026 20-F FORM 20-F Mar 5, 2026 6-K FORM 6-K Mar 5, 2026 6-K FORM 6-K Mar 2, 2026 6-K FORM 6-K Feb 27, 2026 6-K FORM 6-K Jan 13, 2026 6-K FORM 6-K Jan 7, 2026 6-K FORM 6-K Dec 19, 2025 6-K FORM 6-K Dec 10, 2025 6-K FORM 6-K Dec 8, 2025 6-K FORM 6-K Nov 20, 2025 6-K FORM 6-K Nov 18, 2025 6-K FORM 6-K Nov 12, 2025 6-K FORM 6-K Nov 7, 2025 6-K FORM 6-K Nov 6, 2025 6-K FORM 6-K Nov 3, 2025 6-K/A FORM 6-K/A Oct 31, 2025 6-K FORM 6-K Oct 31, 2025 6-K FORM 6-K Oct 30, 2025 6-K FORM 6-K Oct 30, 2025 6-K FORM 6-K Oct 27, 2025 6-K FORM 6-K Oct 17, 2025